Fundraising Fox
Anodyne
Boston, US · Founded 2019 · 6 known investors
Find your way into Anodyne
Sign up to see every warm intro you have to Anodyne
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Anodyne team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Anodyne Nanotech develops the HeroPatch, a transdermal drug delivery system designed to replace traditional injections for chronic care treatments. The company focuses on simplifying medicine delivery through an alternative to needles and syringes.
Founders & leadership
LJ
LOMBARDO JAKECo-Founder & CEOExecutive officer at Anodyne Nanotech, which works on drug delivery technology.
VL
Vikram LambaNamed on SEC filing
GP
Georgios PapastergiouNamed on SEC filing
KT
Konstantinos TzortzakisNamed on SEC filing
JL
Jake LombardoNamed on SEC filing
HR
HOJATOLLAH REZAEI NEJADNamed on SEC filing
LK
LAMPROS KOURTISNamed on SEC filing
Board
MS
Michael SingerBoard director
AG
ACHILLEAS GRAVANISBoard director
Investors · 6
Bantam Grouplisted by Bantam GroupWestwood
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 3
Evercurious VCRelativity Healthcare PartnersVelocity Partners VClead
Funding
SEC filings, press & company announcements$16M disclosed across 3 of 5 rounds · 2020–2026
- Undisclosed amountSeries AJun 2026
Velocity Partners VC (lead), Evercurious VC, Relativity Healthcare Partners
Source ↗ - Undisclosed amountSeedMay 2024Source ↗
▶$12.6MraisedJun 2026 · 47 investors · Other Health CareRule 506(b)
▶$12.6MraisedJun 2026 · 47 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael SingerDirector
- Vikram LambaDirector
- Georgios PapastergiouDirector
- Konstantinos TzortzakisExecutive Officer, Director
- Jake LombardoExecutive Officer, Director
- Offering amount
- $17.3M
- Amount sold
- $12.6M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedMay 2021 · 15 investors · Other TechnologyRule 506(b)
▶$2MraisedMay 2021 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL SINGERDirector
- HOJATOLLAH REZAEI NEJADExecutive Officer
- KONSTANTINOS TZORTZAKISExecutive Officer, Director
- LOMBARDO JAKEExecutive Officer
- LAMPROS KOURTISDirector
- ACHILLEAS GRAVANISDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.5MraisedAug 2020 · 20 investors · Other TechnologyRule 506(b)
▶$1.5MraisedAug 2020 · 20 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- KONSTANTINOS TZORTZAKISExecutive Officer, Director
- ACHILLEAS GRAVANISDirector
- LOMBARDO JAKEExecutive Officer
- LAMPROS KOURTISDirector
- MICHAEL SINGERDirector
- HOJATOLLAH REZAEI NEJADExecutive Officer
- Offering amount
- $2.3M
- Amount sold
- $1.5M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Anodyne do?
- Anodyne Nanotech develops the HeroPatch, a transdermal drug delivery system designed to replace traditional injections for chronic care treatments. The company focuses on simplifying medicine delivery through an alternative to needles and syringes.
- Who are Anodyne's investors?
- Anodyne's investors include Bantam Group, Big Pi Ventures, EvercuriousVC.
- How much funding has Anodyne raised?
- Anodyne has disclosed $16M raised across 3 of its 5 known rounds.
- Where is Anodyne headquartered?
- Anodyne is headquartered in Boston, US.